Literature DB >> 31894332

Long non‑coding RNA LINC00312 regulates breast cancer progression through the miR‑9/CDH1 axis.

Yajun Chen1, Fanghua Qiu2, Lichan Huang1, Weiping Liu3, Liqin Li4, Canhua Ji4, Xianqi Zeng1, Lingli Qiao1, Mengqin Liu1, Xiaoqian Gong3.   

Abstract

Long non‑coding RNAs (lncRNAs) are important mediators of the initiation and progression of tumors, including breast cancer (BC). The exact role of long intergenic non‑coding RNA 00312 (LINC00312) in BC and its mechanism of action have not been reported to date. In the present study, LINC00312 was found to be downregulated in human BC tissues and cell lines by RT‑qPCR. The findings of a functional study indicated that overexpression of LINC00312 suppressed the proliferation, colony forming ability, migration and invasiveness of BC cell lines. Mechanistically, LINC00312 was found to induce suppression of cell migration and invasion by directly binding to miR‑9. Overexpression of LINC00312 increased the expression of cadherin 1 (CDH1), a direct target of miR‑9, and decreased the expression of vimentin (VIM), a major cytoskeletal component of mesenchymal cells as determined by western blot analysis. miR‑9 partly abrogated the upregulation of CDH1 and downregulation of VIM induced by LINC00312. Taken together, the results of the present study indicate a role for the LINC00312/miR‑9/CDH1 axis in the progression of BC, and suggest a novel lncRNA‑based diagnostic biomarker or therapeutic target for BC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31894332     DOI: 10.3892/mmr.2019.10895

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Long Noncoding RNA LINC00173 Promotes NUTF2 Expression Through Sponging miR-765 and Facilitates Tumorigenesis in Glioma.

Authors:  Qinghua Du; Jin Liu; Da Tian; Xuelei Zhang; Jinwei Zhu; Weiwen Qiu; Jun Wu
Journal:  Cancer Manag Res       Date:  2020-08-12       Impact factor: 3.989

2.  Knockdown of Long Noncoding RNA 01124 Inhibits the Malignant Behaviors of Colon Cancer Cells via miR-654-5p/HAX-1.

Authors:  Yu-Jin Wu; Zhi-Quan Cai; Run-Ming He; Xue-Chuan Wang; Long-Ling Cong; Fang-Hua Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

3.  Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.

Authors:  Rubén Rodríguez-Bautista; Claudia H Caro-Sánchez; Paula Cabrera-Galeana; Gerardo J Alanis-Funes; Everardo Gutierrez-Millán; Santiago Ávila-Ríos; Margarita Matías-Florentino; Gustavo Reyes-Terán; José Díaz-Chávez; Cynthia Villarreal-Garza; Norma Y Hernández-Pedro; Alette Ortega-Gómez; Luis Lara-Mejía; Claudia Rangel-Escareño; Oscar Arrieta
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.